Serum interleukin-6 level after cardiac xenotransplantation in primates.
Matsumiya
G
G
Department of Immunology, and Pathology, Loma Linda University School of Medicine, California 92354, USA.
Gundry
S R
SR
Nehlsen-Cannarella
S
S
Fagoaga
O R
OR
Morimoto
T
T
Arai
S
S
Fukushima
N
N
Zuppan
C W
CW
Bailey
L L
LL
D000818:Animals; D015415:Biomarkers / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015850:Interleukin-6 / Q000097:blood*; D008253:Macaca mulatta; D008727:Methotrexate / Q000627:therapeutic use; D010215:Papio; D011183:Postoperative Complications; D016559:Tacrolimus / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000502:physiology
D015415:Biomarkers; D006146:Guanidines; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D016572:Cyclosporine; C037258:gusperimus; D016559:Tacrolimus; D008727:Methotrexate